Screening and identification of SUMP-proteins in sub-acute treatment with diazinon

Publish Year: 1394
نوع سند: مقاله ژورنالی
زبان: English
View: 233

This Paper With 5 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-18-12_012

تاریخ نمایه سازی: 3 آبان 1400

Abstract:

Objective(s):Small ubiquitin-like modifiers (SUMOs) are a family of ubiquitin-related, proteins that are involved in a wide variety of signaling pathways. SUMOylation, as a vital post translational modification, regulate protein function in manycellular processes. Diazinon (DZN), an organophosphate insecticide, causses oxidative stress and subsequently programmed cell death in different tissues. The aim of this study was to evaluate the role and pattern of SUMO modificationas a defense mechanism against stress oxidative, in the heart tissuesof the DZN treated rats. Materials and Methods: Diazinon (۱۵ mg/kg/day), corn oil (control) were administered via gavageto male Wistar rats for four weeks. SUMO۱ antibody was covalently crosslinked to protein A/G agarose. heart tissue lysate were added to agarosebeads,After isolation of target proteins(SUMO۱- protein)SDS-PAGE gel electrophoresis was performed. Protein bands were identified using MALDI-TOF/TOF and MASCOT). Fold change of (DZN/Ctrl) separated proteins was evaluated using UVband software (UVITEC, UK). Results:Our result showed that subacute exposure to DZN increased SUMOylationoffour key proteins involved in the metabolic process including; Acyl-CoA dehydrogenase, creatine kinase, glyceraldehyde-۳-phosphate dehydrogenase and ATP synthase, in the heart tissue of animals .A probability value of  less than ۰.۰۵ was considered significant (P<۰.۰۵). Conclusion: It seems that protein SUMOylation provides a safeguard mechanism against DZN Toxicity.

Authors

Rezvan Yazdian-Robati

Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Atena Pourtaji

Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Marzieh Rashedinia

Department of Toxicology and pharmacology, School of Pharmacy, international branch, Shiraz University of Medical Sciences, Shiraz, Iran

Hossein Hosseinzadeh

Pharmaceutical Research Center, Department of Pharmacology and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Maryam Ghorbani

Department of Pharmacology and Toxicology, School of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran

BiBi Marjan Razavi

Targeted Drug Delivery Research Center, Department of Pharmacology and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Mohammad Ramezani

Pharmaceutical Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Khalil Abnous

Pharmaceutical Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Baczyk D, Drewlo S, Kingdom JC. Emerging role of SUMOylation ...
  • Girdwood DW, Tatham MH, Hay RT. SUMO and transcriptional regulation.Cell ...
  • ۳.Desterro JMP, Rodriguez MS, Hay RT. SUMO-۱ Modification of IκBα ...
  • Bawa-Khalfe T, Yeh ET. SUMO Losing Balance: SUMO Proteases Disrupt ...
  • ۵.Dasso M. Emerging roles of the SUMO pathway in mitosis. ...
  • ۶.Terashima T, Kawai H, Fujitani M, Maeda K, Yasuda H. ...
  • Pountney DL, Huang Y, Burns RJ, Haan E, Thompson PD, ...
  • ۸.McMillan LE, Brown JT, Henley JM, Cimarosti H. Profiles of ...
  • ۹.Hay RT. SUMO: a history of modification. Mol Cell. ۲۰۰۵;۱۸:۱-۱۲ ...
  • Dangoumau A, Veyrat-Durebex C, Blasco H, Praline J, Corcia P, ...
  • Shah MD, Iqbal M. Diazinon-induced oxidative stress and renal dysfunction ...
  • Ogutcu A, Uzunhisarcikli M, Kalender S, Durak D, Bayrakdar F, ...
  • Razavi BM, Hosseinzadeh H, Movassaghi AR, Imenshahidi M, Abnous K. ...
  • ۱۴.Handy RD, Abd-El Samei HA, Bayomy MF, Mahran AM, Abdeen ...
  • Yavuz T, Delibas N, Yildirim B, Altuntas I, Candır O, ...
  • Feligioni M, Nistico R. SUMO: a (oxidative) stressed protein. Neuromolecular ...
  • Jafari M, Salehi M, Ahmadi S, Asgari A, Abasnezhad M, ...
  • Yang P, Hu S, Yang F, Guan X-Q, Wang S-Q, ...
  • Sirover MA. New insights into an old protein: the functional ...
  • Hariri AT, Moallem SA, Mahmoudi M, Memar B, Hosseinzadeh H. ...
  • Agbor TA, Cheong A, Comerford KM, Scholz CC, Bruning U, ...
  • Kim KI, Baek SH. Small ubiquitin-like modifiers in cellular malignancy ...
  • Bell RD, Khan M. Cerebrospinal fluid creatine kinase-BB activity: a ...
  • Konorev EA, Hogg N, Kalyanaraman B. Rapid and irreversible inhibition ...
  • Venkataraman P, Krishnamoorthy G, Selvakumar K, Arunakaran J. Oxidative stress ...
  • Schlattner U, Tokarska-Schlattner M, Wallimann T. Mitochondrial creatine kinase in ...
  • Zhang X, Takano T, Liu S. Identification of a mitochondrial ...
  • Martinez-Reyes I, Cuezva JM. The H(+)-ATP synthase: a gate to ...
  • Johnson ES. Protein modification by SUMO. Annual review of biochemistry. ...
  • Pandey D, Chen F, Patel A, Wang CY, Dimitropoulou C, ...
  • نمایش کامل مراجع